Last edition
News about
Lupin Announces Resolution of US FDA Warning Letter for its Goa and Pithampur Facilities
This is after the satisfactory evaluation of the corrective actions taken by the company in response to the Warning Letter that was issued on November 6, 2017.
AmbioPharm Aims Global Peptide CDMO Expansion with China and US Facilities
A reliable peptide CDMO with manufacturing facilities both in China and the USA, AmbioPharm is ready to meet the needs of a global market.
Scottish Researchers Explore Use of PET Plastic for Manufacturing Pharmaceuticals
Using genetically modified bacteria and enzymes to break down the plastic waste, the core chemical components can then be converted into valuable pharmaceuticals.
Axplora Opens New cGMP Pilot Facility for Flow Chemistry
The new facility is part of the company’s investment in differentiated and specialized technologies.
Revenue of Indian Pharmaceutical Firms to Grow by 7-9 Percent in FY2024, Reports ICRA
USFDA inspections have gained momentum in the recent past and regulatory risks remain a key monitorable.
ARTBIO and SpectronRx Enter a Collaboration to Manufacture Key Components of ARTBIO's AlphaDirect™ Technology
Biocon gets 8 observations from USFDA after inspection of Malaysia insulins facility
Biocon gets 8 observations from USFDA after inspection of Malaysia insulins facility
Aurobindo Pharma Ltd gets 3 observations from USFDA for Unit 3 at Bachupally Village
Aurobindo Pharma Ltd gets 3 observations from USFDA for Unit 3 at Bachupally Village
Lupin receives tentative approval from U.S. FDA for Dolutegravir Lamivudine and Tenofovir Alafenamide Tablets
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy